abstract |
The invention belongs to the technical field of monoclonal antibodies, and specifically discloses a novel coronavirus RBD-specific monoclonal antibody and the application of the above-mentioned novel coronavirus RBD-specific monoclonal antibody. The invention has important scientific significance and application prospect for the prevention, clinical treatment and research and development of diagnostic reagents caused by the novel coronavirus SARS-CoV-2. |